VRCA
Verrica Pharmaceuticals Inc.
Latest Form 4:Purchase$21KbyRosenberg Noah L. (CMO) · filed Aug 18, 2026
Verrica Pharmaceuticals Inc. (VRCA) has 10 SEC Form 4 filings (13 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Aug 18, 2026.
Inside the rolling window, 5 insiders at Verrica Pharmaceuticals Inc. reported 11 open-market purchases totaling $18.2M and no open-market sales. The most active filer is CMO Rosenberg Noah L. with 3 filings. Insiders have net bought $211K over the trailing 6 months. The most recent open-market filing is a purchase of 4,200 shares by CMO Rosenberg Noah L., dated Aug 17, 2026, worth $21K.
- Industry:Biotechnology
- CEO:Jayson Rieger
- Employees:76
- HQ:West Chester, PA, US
- IPO:2018-06-15
Insider Buying
$18.2M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Market Cap
$90.0M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Rosenberg Noah L.First in 9 months | CMO | Purchase | 4,200 | $21K | Aug 18 | SEC ↗ |
Rosenberg Noah L.First in 9 months | CMO | Purchase | 2,030 | $10K | Aug 18 | SEC ↗ |
Rieger JaysonFirst in 9 months | CEO and President | Purchase | 20,000 | $101K | Aug 18 | SEC ↗ |
Rieger JaysonFirst in 9 months | CEO and President | Purchase | 5,000 | $25K | Aug 18 | SEC ↗ |
Zawitz DavidFirst in 9 months | Chief Operating Officer | Purchase | 6,000 | $30K | Aug 18 | SEC ↗ |
Kirby John J.First in 9 months | Interim CFO | Purchase | 5,000 | $25K | Aug 18 | SEC ↗ |
Manning Paul BFirst filing | Director, 10% Owner | Purchase | 4,126,142 | $17.5M | Nov 25 | SEC ↗ |
Kirby John J.First filing | Interim CFO | Purchase | 3,536 | $15K | Nov 25 | SEC ↗ |
Rosenberg Noah L.First filing | CMO | Purchase | 2,357 | $10K | Nov 25 | SEC ↗ |
Rieger JaysonFirst filing | CEO and President | Purchase | 94,311 | $400K | Nov 25 | SEC ↗ |
Zawitz DavidFirst filing | Chief Operating Officer | Purchase | 10,000 | $42K | Nov 25 | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does VRCA have?
Verrica Pharmaceuticals Inc. (VRCA) has 10 SEC Form 4 filings (13 transaction rows) in the rolling 365-day window, disclosed by 5 distinct insiders. Most recent filing: Aug 18, 2026.
When was the most recent SEC Form 4 filing for VRCA?
The most recent Form 4 filing for VRCA on Tracefour is dated Aug 18, 2026.
Who is the most active insider at VRCA?
The most active SEC Form 4 filer at VRCA in the rolling window is CMO Rosenberg Noah L., with 3 filings.
What is the net insider flow at VRCA over the last 6 months?
Over the trailing 180 days, insiders at VRCA have net bought $211K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at VRCA in the current window?
Inside the rolling window, insiders at VRCA bought $18.2M and sold $0 based on SEC Form 4 filings.
Can I get alerts for VRCA insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Verrica Pharmaceuticals Inc. (VRCA). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Verrica Pharmaceuticals Inc. is in the Healthcare sector.